2021 Digital Therapeutics for Obesity and Eating-Related Problems
페이지 정보
작성자 최고관리자 작성일 24-07-03 16:02본문
- Journal
- Endocrinology and Metabolism
- Journal Info
- 36(2)
- Year
- 2021
Digital therapeutics (DTx) have emerged as a promising solution to manage medical conditions using digital technologies. They leverage advancements in digital tools to monitor and improve both physical and mental health, particularly in managing obesity and eating behavior problems through lifestyle modifications.
As these technologies continue to evolve, it's crucial to address key issues to enhance their effectiveness in future development. Collaboration among stakeholders such as health professionals, patients, guardians, industry partners, and policy-makers is essential. This collaboration ensures that DTx are adapted effectively and made accessible to the public.
By fostering partnerships and integrating feedback from various stakeholders, we can optimize DTx to better serve healthcare needs. This approach not only enhances treatment outcomes but also promotes broader access to innovative health solutions in the digital age. Thus, DTx represent a significant advancement in healthcare delivery, offering scalable and effective treatments for managing obesity and related conditions.
관련링크
- 이전글Machine-learning analysis identifies digital behavioral phenotypes for engagement and health outcome efficacy of mHealth interventions for obesity: post-hoc analyses of a randomized trial 24.07.03
- 다음글Mental health of people with distorted body weight perception using medicinal remedies: a representative study 24.07.03